The availability and applicability of the combination of paramagnetic nitroxyl contrast agent and T 1weighted gradient echo (GE)-based dynamic magnetic resonance imaging (MRI) measurement for redox imaging are described. The time courses of T 1 -weighted GE MRI signal intensities according to first-order paramagnetic loss of a nitroxyl contrast agent were simulated for several experimental conditions. The apparent decay rate calculated based on decreasing T 1 -weighted MRI contrast (k MRI ) can show an approximate value of the original decay rate (k true ) discretionarily given for simulation with suitable experimental parameters. The difference between k MRI and k true can be sufficiently small under T 1 -weighted spoiled gradient echo (SPGR) scan conditions (repetition time‫؍‬ ‫57؍‬ ms, echo time‫؍‬ ‫3؍‬ ms, and flip angle‫؍‬ ‫,)°54؍‬ with a conventional redox-sensitive nitroxyl contrast agent, such as 4-hydroxy-2,2,6,6,-tetramethylpiperidine-N-oxyl (TEMPOL) and/or 3-carbamoyl-2,2,5,5tetramethylpyrrolidine-N-oxyl (carbamoyl-PROXYL), and with i.v. doses of below 1.5 m mmol/g b.w. for mice. The results of this simulation suggest that the k MRI of nitroxyl contrast agents can be the primary index of redox status under biological conditions.
Nitroxyl radicals have been widely used as a free radical probe for electron paramagnetic resonance (EPR) spectroscopy and EPR imaging (EPRI) to investigate in vivo redox conditions. [1] [2] [3] [4] [5] [6] The enzymatic or chemical reduction system reduces nitroxyl radicals to the corresponding hydroxylamine, [7] [8] [9] [10] [11] [12] enabling us to estimate the redox status in vivo. Hypoxic conditions in the tumor, [13] [14] [15] biological reducing agents, 16, 17) and oxidative stresses accompanying the synthesis of superoxide and/or hydroxyl radical [18] [19] [20] can enhance the reduction of nitroxyl radicals in vivo. In contrast, oxidative conditions in a tissue could apparently decrease the in vivo reduction rate of nitroxyl radicals due to the re-oxidation of hydroxylamine to the original nitroxyl radical. 21) The feasibility of nitroxyl radicals as T 1 -enhancing magnetic resonance imaging (MRI) contrast agents has been described since the early 1980s. 22, 23) Since the T 1 relaxation of protons can be affected by paramagnetic nitroxyl electron spin, changing the MRI contrast before and after administration of the nitroxyl contrast agent can reflect the amount of nitroxyl contrast agent in addition to providing simultaneous anatomical mapping, similar to Gd 3ϩ . Despite a number of pharmacokinetic studies, 7, 24, 25) rapid in vivo reduction of the nitroxyl contrast agent was not as useful as an MRI contrast agent in early 1980s. 26) At that time, relatively low T 1 relaxivity of nitroxyl contrast agents was another problem for obtaining clinically and/or experimentally utilizable T 1 -contrast enhancement. Recently, high-power magnet MRI instrumentation, such as 4.7 T, with a T 1 -weighted spoiled gradient echo (SPGR) pulse sequence has enabled us to take a fresh look at the feasibility of employing nitroxyl radicals as MRI contrast agents. [27] [28] [29] The redox status of the tumor and normal tissue can be reflected in the time course of T 1 contrast after the injection of a paramagnetic nitroxyl contrast agent to an experimental animal.
Gradient echo (GE)-based T 1 -weighted contrast imaging is fast and is suitable for dynamic imaging, although T 1weighted MRI contrast can not be utilized to quantify the amount of contrast agent directly. The pseudo decay rate calculated based on decreasing T 1 -weighted MRI contrast can show a similar value to the decay rate obtained by EPR measurement when an identical phantom sample is measured by both methods. 27, 28) In vivo experiments which compared the decay rates of a nitroxyl contrast agent between normal and tumor tissues of a mouse also showed similar results between EPRI and MRI experiments. 27, 28) Several problems on EPRI, such as lack of anatomical information, low spatial resolution, low temporal resolution, and relatively small sample volume, can be solved using MRI; however, the pseudo decay rate obtained based on T 1weighted MRI contrast is not a theoretically true decay rate because the detection of nitroxyl radical using MRI is indirect, based on the enhancement of T 1 contrast instead of the direct detection of radio frequency (RF) absorption. Therefore, the theoretical reliability of the pseudo decay rate based on T 1 -weighted MRI contrast should be evaluated.
In this paper, signal intensity changes of T 1 -weighted GE MRI according with the first-order concentration decay of paramagnetic nitroxyl contrast agents were calculated by assuming possible in vivo experimental conditions. Whether this surrogate decay rate calculated based on decreasing T 1weighted MRI contrast can be used as a fallback position was discussed to ensure in vivo redox mapping based on T 1weighted MRI, which was reported elsewhere. [27] [28] [29] In addition, the suitability of conventional nitroxyl paramagnetic contrast agents, such as 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPOL) and 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CmP), as redox probes for MR redox imaging based on T 1 -contrast was also discussed. MRI Measurement The phantom was composed of seven tubes (4.7 mm i.d.) containing 0, 0.25, 0.50, 0.75, 1.0, 1.5, 2.0 mM aqueous solution of a nitroxyl contrast agent, i.e., CmP, TEMPOL, or 15 N-TPN. The shape of the phantom is shown in Fig. 1A . MRI measurement was performed at 4.7 T controlled with ParaVision ® 3.0.1 (Bruker BioSpin MRI GmbH, Ettlingen, Germany). SPGR (also referred to as gradient echo fast imaging, GEFI) (TRϭ75 ms, TEϭ3 ms, FAϭ 45°, N EX ϭ16) was employed to observe the T 1 effect, where N EX is number of excitations and see Table 1 for other abbreviations. The scan time for an image set (which included 2 slices) by the SPGR sequence was 120 s. Other image parameters are as follows: image resolution was 256ϫ256, field of view (FOV) was 3.2ϫ3.2 cm, slice thickness was 2.0 mm. Sample temperature was monitored and kept at 37°C using a water circulating system. DM%, which is the enhancement of image intensity from the baseline, was calculated using the intensity of the center tube (water) as the baseline:
MATERIALS AND METHODS

Materials
DM%ϭpixel intensity/ (average intensity in the center tube)ϫ100Ϫ100 (1) MRI data were analyzed using the ImageJ software package (a public domain Java image-processing program inspired by NIH Image that can be extended by plug-ins, http://rsb.info. nih.gov/ij/). Simulation SPGR image intensity M t in a tissue at time t (min) after injection of a nitroxyl contrast agent was calculated by an equation:
where M 0 is proton density and FA is the flip angle. T 1t , which is the T 1 value obtained in the tissue at a particular time t, changes depending on the concentration of the ni-troxyl contrast agent (C t ) in the tissue. T 2 * was assumed to be constant before and after injection of the nitroxyl contrast agent in this simulation. The concentration of nitroxyl contrast agent applied in this simulation was low enough to eliminate the effect to T 2 *.
where R 1t is the T 1 relaxation rate at time t, T 1i is the initial T 1 baseline (intrinsic T 1 of tissue itself), and r 1 is the relaxiv- ity of the nitroxyl contrast agent. C t (mM), which is the concentration of the nitroxyl contrast agent in the tissue at a particular time t, was calculated by assuming a first-order decay equation:
where k true is the given decay rate. Logarithmic values of the intensity enhancement (difference from the baseline), i.e.,
were plotted against time t. M i is the intrinsic signal intensity of tissue calculated as C t ϭ0. The decay constant k MRI is obtained from the slopes of plotted DM% t using least squares fit through origin. All calculations and plots were carried out using Microsoft Excel XP. The variables used in this simulation are summarized in Table 1 .
RESULTS
A phantom study showed the relation between T 1 -contrast enhancement (DM%) and the concentration of a nitroxyl contrast agent experimentally. MR image intensity shows the concentration-dependent difference of solutions in tubes ( Fig. 1B) . For phantom experiments, the average intensity of the center tube (water) was used as the baseline to calculate DM% for each tube. Therefore, the fluctuations of DM% values were large in such baseline correction. Slopes between experimentally obtained DM% and the concentrations of nitroxyl contrast agents, however, showed similar slopes around the simulated one (dotted line in Fig. 1C ). The simulation was performed as below. Figure 2 shows the calculated MRI intensity change (DM%) depending on the concentration of a nitroxyl contrast agent in water. T 1 relaxivity for a nitroxyl contrast agent at 37°C was experimentally estimated as r 1 ϭ0.13 mM Ϫ1 s Ϫ1 from T 1 mapping of the same phantoms used in previous experiments. T 1 of the water used in this simulation, i.e., T 1i , was estimated as 2350 ms. The relation between the concentration of the paramagnetic contrast agent and T 1 -weighted signal enhancement was not actually linear in a wide concentration window (0-10 mM) ( Fig. 2A ), while relatively good linearity was obtained in a lower concentration window (0-2 mM) ( Fig. 2B ). The profile shape of the DM% concentration curve changed depending on relaxivity r 1 . The linear region became shorter with larger r 1 (data not shown).
Time courses of simulated MRI contrasts, DM% t , were calculated using several decay rates as input values, i.e., k true from 0.02 to 1.50 min Ϫ1 . A plot of ln(DM% t ) versus time t gave an almost linear decay, and then the decay constant of DM%, i.e., k MRI , was estimated from the slope of an identical time window from tϭ0 to tϭ5 min. The k MRI showed a similar but slightly smaller value than the given k true . The error between k MRI and k true (percentage difference of k MRI from k true ), Error%, was estimated as below:
Error%ϭ(1Ϫk MRI /k true )ϫ100 (7) The relationship between Error% and k true was observed under several conditions and compared. Figure 3A indicates the relationship between Error% and the given k true when the given C max was changed. Other parameters used in the calculation were fixed as follows: TRϭ 75 ms, TEϭ3 ms, FAϭ45°, and T 1i ϭ2350 ms. Error% became larger when the given k true became slower. When the given C max became larger, the Error% became larger and sensitively increased in the lower k true region. Error% was, however, under 5% for all cases simulated here.
Similarly, Fig. 3B indicates the relationship between Error% and the given k true values obtained using several T 1i values as inputs. Other parameters used in the calculation were fixed as C max ϭ1.5 mM, TRϭ75 ms, TEϭ3 ms, and FAϭ 45°. Error% became larger when the given k true became slower. The effect of a given T 1i on Error% was small when T 1i was smaller than 500 ms. Error% was under 5% when T 1i was smaller than 500 ms; however, Error% was beyond 5% when T 1i ϭ250 ms and k true Ͻ0.126 min Ϫ1 was used. Figure 3C indicates the relationship between Error% and given k true values obtained using several TR values as inputs. Other parameters used in the calculation were fixed as follows: C max ϭ1.5 mM, T 1i ϭ2350 ms, TEϭ3 ms, and FAϭ45°. The effect of TR on Error% was small and Error% was under 5% for all cases tested here. Figure 3D indicates the relationship between Error% and the given k true values obtained using several FA values as inputs. Other parameters used in the calculation were fixed as follows: C max ϭ1.5 mM, T 1i ϭ2350 ms, TRϭ75 ms, and TEϭ 3 ms. Error% very slightly changed when inputs of FA changed; however, the effect of FA was small. Error% was under 5% for all cases tested here. Figure 3E indicates the relationship between Error% and the given k true values obtained using several r 1 values as inputs. Other parameters used in the calculation were fixed as follows: C max ϭ1.5 mM, T 1i ϭ2350 ms, TRϭ75 ms, TEϭ3 ms, and FAϭ45°. Error% was under 5% when r 1 was smaller than 1.5 mM Ϫ1 s Ϫ1 and most of r 1 ϭ2.0. When r 1 ϭ0.3 was used, Error% was over 5% in the region of k true Ͻ0.222 min Ϫ1 . When r 1 ϭ0.5 was used, Error% was over 5% in the region of k true Ͻ0.487 min Ϫ1 , and over 10% in the region of k true Ͻ0.138 min Ϫ1 .
DISCUSSION
The T 1 shortening effect of a contrast agent roughly depends on the number of unpaired electrons on its molecules. Most of the nitroxyl probe, which has one unpaired electron on its molecules, showed similar T 1 relaxivity. 30) Three different nitroxyl contrast agents in this paper also showed similar T 1 enhancement. Many characteristic nitroxyl molecules have been synthesized according to the purpose of each experiment and reported. Some of these nitroxyls may be found as redox-sensitive MR contrast agents. The results in this paper showed that most of nitroxyl radicals with one unpaired electron can be applied to MR redox imaging based on T 1 -weighted GE scan.
The potential of nitroxyl radicals and/or hydroxylamines as a redox-sensitive contrast agent for MRI has been proposed in earlier studies. 31, 32) Recent high-power magnet MRI instrumentation, such as 4.7 T, with a T 1 -weighted SPGR pulse sequence, has enabled us to examine T 1 enhancement sensitively, for example, T 1 enhancement under hyperbaric oxygenation in mice. 33) Scan parameters used in the phantom experiment in this paper were employed according to the parameters used in our previous paper. 33) Suitable values of these parameters were estimated by previous simulation, and then decided through practical experiments to detect T 1 enhancement by oxygen in vivo. When nitroxyl contrast agents were applied to the same T 1 -weighted pulse sequence scan, [27] [28] [29] a more pronounced contrast difference (DM%) was expected to be obtained.
The reciprocal of T 1 , i.e., relaxation rate R 1 ϭ1/T 1 , has a linear relation to the concentration of the contrast agent. The enhancement magnitudes of T 1 -weighted signal intensity by the contrast agent do not have a linear relation to the concentration of the contrast agent. An approximately linear relation can be obtained for the lower concentration region, when relaxivity r 1 was small (r 1 was 0.13 mM Ϫ1 s Ϫ1 in this simulation). Although this is not exactly linear, quantification in such a concentration region is possible when an identical solvent, i.e., identical T 1i , is considered for all experiments. When animal experiments are considered, however, quantification is difficult. Signal intensity M t can be calculated by Eq. 2, in which M t is a function of T 1t . T 1t is composed of intrinsic tissue T 1 , i.e., T 1i , and induced T 1 by a contrast agent, i.e., 1/(r 1 ϫC t ). T 1 was composed by the addition of R 1 (reciprocal of T 1 ); therefore, this addition causes a difference in the slope of ln(DM% t ), i.e., k MRI , at each time point and shows the error from k true .
It can be predicted that the variables in Eq. 2 will cause errors between k true and k MRI . In fact, Error% was larger with slower k true , larger C max , shorter T 1i , longer TR, smaller FA, and/or larger r 1 . TE and intrinsic tissue T 2 * affected the values of M t , similar to DM% t , but not the decay rate of ln(DM% t ). Effects of scan parameters, i.e., TR and FA, on Error% were sufficiently small, and Error% was always below 5% in this simulation when default values were used as other inputs. The slow decay rate should be estimated carefully, especially in tissue with shorter T 1i . In addition, approximation of the slower decay rate may become inaccurate when a nitroxyl contrast agent with large r 1 is used. Effects of experimental parameters, i.e., C max , can be adjusted by choosing the experimental dose or by choosing a time window for estimating the decay rate in data manipulation.
Under identical experimental conditions, i.e., identical dose of a contrast agent and fixed scan parameters, k MRI values will be slightly affected only by T 1i . Error% can be less than 4% for k true faster than 0.02 min Ϫ1 , when T 1i is 750 ms, TR is 75 ms, and FA is 45°. Error% can be smaller for faster k true , and less than 2% when k true is larger than 0.3 min Ϫ1 . Effect of T 1i on Error% was sufficiently small when given T 1i was longer than 500 ms; however, Error% became slightly higher when the given T 1i was 250 ms. T 1 values of approximately 790 and 1000 ms for normal muscle and SCC tumor tissues, while approximately 250 ms for fat tissue, can be estimated from our previous work. 32) Several tissues, such as the liver and brain (white matter), may show 500-600 ms T 1 ; therefore, the estimation of tissue redox status based on the time course of nitroxyl-caused T 1 enhancement can be realized in practical in vivo experiments targeting muscle, brain, or other soft tissues, except when tissues have shorter T 1i , such as fat. Comparison of k MRI among different tissues needs careful consideration of the differences achieved by different tissue-specific T 1 , especially for tissues with short 714
Vol. 32, No. 4 Fig. 3 . Relationship between Error% and Given k true Calculated for Several Conditions T 1 . Preliminary T 1 mapping of the experiment is recommended. When a general in vivo experimental dose (Ͻ1.5 mmol/g body weight (b.w.) by bolus injection) of a nitroxyl contrast agent was administered via intravenous (i.v.) injection to a mouse, blood concentration may immediately increase, and then start to decay through diffusion, reduction, and excretion; therefore, initial high blood concentration may underestimate k MRI . When 1.5 mmol/g b.w. of TEMPOL or CmP was injected by bolus i.v. administration, the blood concentration of the nitroxyl contrast agent is expected to be below 1.5 mM, 0.8 and 2.5 min after the injection, respectively. 34) At the same time, the tissue concentration of either TEMPOL or CmP is predicted to be below 0.5 mM. Since the quite fast in vivo decay rates of TEMPOL may be faster than 1.0 min Ϫ1 , errors between k true and k MRI might remain below 2.8%, even if C max is 6 mM. The blood concentration of 6 mM of TEM-POL can reach 0.4 min after i.v. administration. The k MRI should therefore be estimated from data after those time points. This suggests that conventional nitroxyl paramagnetic contrast agents, such as TEMPOL and CmP, can be good candidates for redox probes for MR redox imaging based on T 1 contrast. In contrast, membrane-impermeable nitroxyl contrast agents, such as carboxy-PROXYL, which may maintain a high blood concentration for a relatively long time, are not suitable MR redox probes.
Changing T 1i and T 2 * before and after injection of the nitroxyl contrast agent should be considered carefully, because these changes can give relatively large errors in k MRI values. The difference between k MRI and k true will become larger, over 10%, when ca. 0.1% of T 1i shortening is assumed as a result of the pharmacodynamic effect of the contrast agent. The k MRI is increased when T 2 * is shortened after injection of a contrast agent; however, the error of k MRI can remain in the range of Ϯ5% when T 2 * shortening after injection is less than 5%. In addition, the effect on T 2 * shortening of the nitroxyl contrast agent is sufficiently small under the concentration used in general in vivo experiments. The difference of k MRI from k true becomes larger when the original T 1i is shorter and when the same R 1i change occurs by injection of the contrast agent. Similarly, the difference of k MRI from k true becomes larger when the original T 2 * is shorter and when the same R 2 * change occurs. A physiological change of T 1i and T 2 * can be expected by a relatively large change of blood flow, blood pressure, etc.; therefore, careful control of anesthetic conditions, body temperature, and breathing rate is necessary for in vivo animal experiments. The k MRI values are complicated even under identical experimental conditions, when such T 1i and T 2 * changes are observed dose dependently. Fortunately, physiological T 1i and T 2 * changes caused by injection of the nitroxyl contrast agent itself are expected to be sufficiently small using a suitable low dose, i.e., under general in vivo experimental conditions. Nitroxyl contrast agents having a single free radical on the molecule showed relatively smaller relaxivity (≈0.13 mM Ϫ1 s Ϫ1 at 4.7 T at 37°C); however, such low relaxivity achieves good linearity between its T 1 contrasts and the concentrations of nitroxyl contrast agents, especially at lower concentrations. Good linearity (R 2 Ն0.9995) was obtained at less than 2 mM for the nitroxyl contrast agent by simulation. This linearity improved in a lower concentration region (R 2 Ն0.9997 at less than 1.5 mM), while linearity fell for a Gd 3ϩ -based contrast agent, which has a relaxivity of around 4 mM Ϫ1 s Ϫ1 at 4.7 T, and the acceptable linear region (R 2 Ն0.999) becomes much shorter (Ͻ0.125 mM approximately). A contrast agent with lower relaxivity can give better quantification ability, while lower relaxivity will result in low SNR. In contrast, higher relaxivity can give good SNR; however, higher relaxivity gave lower linearity of T 1 contrast vs. concentration of the contrast agent. A tri-radical nitroxyl contrast agent, 35) which has relaxivity around 5 mM Ϫ1 s Ϫ1 , may be compoundable.
For exact quantification, the T 1 relaxation time (T 1 relaxation rate) is a quantitative value; however, the generally used spin echo-based quantitative T 1 measurement has too long an acquisition time to estimate the pharmacokinetics of nitroxyl contrast agents. Recently, a super-fast T 1 measurement method has been developed using an EPI-based sequence. 35) Using the time course of T 1 values instead of T 1 -weighted contrasts, an estimation of the true decay rate k true may be available in the future.
Currently, the T 1 -weighted contrast-based pseudo decay rate, i.e., k MRI , is a simplified tool for redox imaging when the experiment is performed under general biological conditions. Although the absolute concentration of the contrast agent is difficult to estimate from T 1 -weighted contrast, the approximate decay constant (k MRI ) of the nitroxyl contrast agent estimated from the time course of T 1 -weighted contrast can be an alternative index of the redox status. Selecting a suitable nitroxyl contrast agent, using suitable scan conditions, and achieving scout T 1 mapping of the identical slice, the decay rate of T 1 -weighted MRI contrast can be utilized as the primary index of redox information in a biological sample.
CONCLUSION
The time course of decreasing T 1 contrast according with the first-order decay (k true ) of the nitroxyl contrast agent was simulated, and the decay rates of MR T 1 contrast (k MRI ) were obtained for several parameter settings. The k MRI gave a slightly smaller value than the given k true . Although k MRI was affected by the initial (maximum) concentration of the paramagnetic nitroxyl contrast agent, intrinsic tissue T 1 , relaxivity of the probe, and scan parameters (TR and FA), the differences between k MRI and k true were sufficiently small when parameters in practical ranges were used. Under suitable experimental conditions, i.e., a practical/low dose of membranepermeable nitroxyl contrast agents, such as TEMPOL and CmP, and a suitable T 1 -weighted pulse sequence, k MRI can be an alternative index of the redox status. In vivo redox mapping based on T 1 -weighted MRI [27] [28] [29] can be an easy tool for redox imaging when the experiment is performed under general biological conditions.
